These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1436473)

  • 1. A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: a time-course study.
    Wood MJ; Sloan DJ; Dallman MJ; Charlton HM
    Neuroscience; 1992 Jul; 49(2):409-18. PubMed ID: 1436473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor.
    Wood MJ; Sloan DJ; Dallman MJ; Charlton HM
    J Exp Med; 1993 Mar; 177(3):597-603. PubMed ID: 8436903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of allogeneic and xenogeneic neuronal tissue transplanted into the third ventricle of rodents.
    Mason DW; Charlton HM; Jones AJ; Lavy CB; Puklavec M; Simmonds SJ
    Neuroscience; 1986 Nov; 19(3):685-94. PubMed ID: 3796814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected?
    Duan WM; Widner H; Björklund A; Brundin P
    Neuroscience; 1993 Nov; 57(2):261-74. PubMed ID: 7906872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat.
    Duan WM; Brundin P; Widner H
    Neuroscience; 1997 Mar; 77(2):599-609. PubMed ID: 9472415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system.
    Pakzaban P; Deacon TW; Burns LH; Dinsmore J; Isacson O
    Neuroscience; 1995 Apr; 65(4):983-96. PubMed ID: 7617173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of mouse corpus callosum grafts in neonatal rat recipients, and the effect of host sensitization.
    Pollack IF; Lee LH; Zhou HF; Lund RD
    J Neurosci Res; 1992 Jan; 31(1):33-45. PubMed ID: 1613822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neural graft function in rats treated with anti-interleukin II receptor antibody.
    Honey CR; Clarke DJ; Dallman MJ; Charlton HM
    Neuroreport; 1990; 1(3-4):247-9. PubMed ID: 1983357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of donor and host blood vessels in CNS allografts.
    Baker-Cairns BJ; Sloan DJ; Broadwell RD; Puklavec M; Charlton HM
    Exp Neurol; 1996 Nov; 142(1):36-46. PubMed ID: 8912897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies.
    Okura Y; Tanaka R; Ono K; Yoshida S; Tanuma N; Matsumoto Y
    J Neurosci Res; 1997 Jun; 48(5):385-96. PubMed ID: 9185663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BN rats do not reject F344 brain allografts even after systemic sensitization.
    Poltorak M; Freed WJ
    Ann Neurol; 1991 Apr; 29(4):377-88. PubMed ID: 1929209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of cyclosporine and splenectomy suppresses interleukin-6 production and major histocompatibility complex class II expression and prolongs cardiac xenograft survival.
    Peterson SM; Strzalka CT; Johnkoski JA; Noble B; Gorfien J; Hoover EL; Bergsland J
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1001-5. PubMed ID: 8159020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats.
    Duan WM; Widner H; Frodl EM; Brundin P
    Neuroscience; 1995 Feb; 64(3):629-41. PubMed ID: 7715776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
    Granstein RD; Goulston C; Gaulton GN
    J Immunol; 1986 Feb; 136(3):898-902. PubMed ID: 3079802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations.
    Broadwell RD; Baker BJ; Ebert PS; Hickey WF
    Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.